Biontech Se (BNTX) SEC Filing 6-K Foreign Issuer report for the period ending Tuesday, May 5, 2020

Biontech Se

CIK: 1776985 Ticker: BNTX

View differences made from one to another to evaluate Biontech Se's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biontech Se.


Assess how Biontech Se's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biontech Se's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Biontech Se provided additional information to their SEC Filing as exhibits

Ticker: BNTX
CIK: 1776985
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001564590-20-020990
Submitted to the SEC: Tue May 05 2020 7:03:48 AM EST
Accepted by the SEC: Tue May 05 2020
Period: Tuesday, May 5, 2020
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: